Shopping Cart 0
Cart Subtotal
USD 0

PendoPharm Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

PendoPharm Inc (PendoPharm), a subsidiary of Pharmascience Inc, is a healthcare company that provides production and commercialization of a wide range of drugs. The company provides products such as spans prescription drugs, over-the-counter and behind-the-counter products, among others. Its prescription product provides drugs for therapeutic areas of gastroenterology, orthopedics and urology. PendoPharm's OTC and BTC products offer allergy, analgesics, cough, cold and sinus, gastroenterology, nasal care and pediatric drugs, among others. The company also provides licensing, development and marketing late-stage specialty prescription medicines and consumer brands. It markets its products across Canada. Pendopharm is headquartered in Montreal, Quebec, Canada.

PendoPharm Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PendoPharm Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

PendoPharm Inc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

PendoPharm Enters into Distribution Agreement with Tillotts Pharma 10

Anika Therapeutics Enters into Agreement with PendoPharm 11

Pendopharm Enters into Distribution Agreement with Sanofi-aventis Canada 12

Licensing Agreements 13

Pendopharm Enters into Licensing Agreement with Edesa Biotech 13

Sigmoid Pharma Enters into Licensing Agreement with PendoPharm for CyCol 14

Paion Exercises Option for Licensing Agreement with PendoPharm for Remimazolam 15

Equity Offering 16

Sigmoid Pharma Raises USD6.3 Million in Private Placement 16

PendoPharm Inc-Key Competitors 17

PendoPharm Inc-Key Employees 18

PendoPharm Inc-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Product News 20

Aug 17, 2017: Introducing the new Lax-A product line for relief of occasional constipation 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

PendoPharm Inc, Pharmaceuticals & Healthcare, Key Facts 2

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PendoPharm Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PendoPharm Inc, Deals By Therapy Area, 2012 to YTD 2018 8

PendoPharm Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

PendoPharm Enters into Distribution Agreement with Tillotts Pharma 10

Anika Therapeutics Enters into Agreement with PendoPharm 11

Pendopharm Enters into Distribution Agreement with Sanofi-aventis Canada 12

Pendopharm Enters into Licensing Agreement with Edesa Biotech 13

Sigmoid Pharma Enters into Licensing Agreement with PendoPharm for CyCol 14

Paion Exercises Option for Licensing Agreement with PendoPharm for Remimazolam 15

Sigmoid Pharma Raises USD6.3 Million in Private Placement 16

PendoPharm Inc, Key Competitors 17

PendoPharm Inc, Key Employees 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

PendoPharm Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.